University of Thessaly (UTH)
H σημασία των μηχανισμών μετά-μεταφραστικής τροποποίησης πρωτεϊνών για την κυτταρική απόκριση στην υποξία και την εμπλοκή της στην καρκινογένεση
Abstract
dc:descriptionHypoxia (oxygen deprivation) is a typical aspect of solid tumors and evokes changes that promote cancer, mainly by activating a small family of transcriptional activators called Hypoxia Inducible Factors (HIFs). HIFs have indeed been associated with tumorigenesis and are, therefore, considered valid targets of anticancer therapy. The oxygen-sensitive HIF-α subunit is additionally controlled by mechanisms involving phosphorylation. Although several kinases are known to regulate HIF-α, the corresponding counteracting phosphatases remain so far unknown.The first part of this thesis concerns the identification of phosphatases that regulate HIF activity. A phosphatome siRNA screening was performed and revealed that two phosphatases, PPP3CA (calcineurin), a calcium-dependent phosphatase, and PDP1 (Pyruvate Dehydrogenase Phosphatase 1), an activator of pyruvate dehydrogenase, affect HIF- dependent transcriptional activity in HeLa cells under hypoxia (1% O2). Additional experiments showed that PPP3CA inhibits HIF activity, since its overexpression or its activation by ionomycin reduced HIF transcriptional activity under hypoxic conditions, without affecting HIF-α protein levels, HIF-1α subcellular localization or its association with HIF-1β. On the other hand, overexpression of PDP1, despite its localization in mitochondria, enhanced HIF-1 activity, which, probably through feedback inhibition, allowed preservation of the phosphorylation levels of PDH by HIF-1-dependent induction of PDK1. However, immunoprecipitation studies did not show any physical interaction between HIF-1α and PPP3CA or PDP1, suggesting that both phosphatases do not directly act on HIF-1α but regulate HIF activity indirectly.The second part of this thesis investigated the possibility to impair the adaptation of cancer cells to hypoxia using HIF-1α-derived peptides that inhibit its phosphorylation by ERK. Following previous studies by the Laboratory of Biochemistry (Faculty of Medicine, University of Thessaly) demonstrating that phosphorylation of HIF-1α by ERK1/2 at Ser641 and Ser643 stimulates HIF-1α activity by blocking its nuclear export, peptides containing the wild-type sequence of the HIF-1α ETD (ERK1/2-Targeted Domain, amino acids 616-658) or ETD forms carrying mutations that destroyed the ERK sites (ETD-SA) or mimicked phosphorylation be ERK (ETD-SE) or destroyed the HIF-1α nuclear export signal (ETD-IA) were designed, cloned, overexpressed in bacteria and purified. These peptides also contained an N-terminal HIV-derived TAT sequence, allowing penetration inside cells and a C-terminal Flag epitope, allowing their detection by specific antibodies. When these peptides were added in the culture medium of hepatocarcinoma Huh7 cells grown under hypoxia (1% O2), they entered the cells and all forms, except ETD-SA, were localized inside the nucleus, caused HIF-1α mislocalization to the cytoplasm, significantly reduced HIF-1 activity and impaired the induction of HIF-1 target genes, without, however, affecting the expression HIF-2 specific gene targets. Furthermore, the nuclear TAT-ETD peptides inhibited the metabolic adaptation, migration and colony formation of cancer cells and triggered their apoptotic death exclusively under hypoxia. Taken together, these data demonstrate the importance of ERK-mediated modification of HIF-1α for cancer cell survival under hypoxia and, in addition, suggest that cell-penetrating TAT-ETD peptides can be used as specific inhibitors of HIF-1 activity and HIF-1-dependent processes required for cellular adaptation to hypoxia and solid tumor growth.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angeliki, Karagiota
- Καραγιώτα, Αγγελική
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44988